Details for New Drug Application (NDA): 063002
✉ Email this page to a colleague
NDA 063002 describes ANCEF IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in one NDA. Additional details are available on the ANCEF IN PLASTIC CONTAINER profile page.
The generic ingredient in ANCEF IN PLASTIC CONTAINER is cefazolin sodium. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
The generic ingredient in ANCEF IN PLASTIC CONTAINER is cefazolin sodium. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
Summary for 063002
| Tradename: | ANCEF IN PLASTIC CONTAINER |
| Applicant: | Baxter Hlthcare |
| Ingredient: | cefazolin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 063002
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG BASE/ML | ||||
| Approval Date: | Mar 28, 1991 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 20MG BASE/ML | ||||
| Approval Date: | Mar 28, 1991 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
